Skip to main content
Kenneth Burman, MD, Endocrinology, Washington, DC

KennethDaleBurmanMD

Endocrinology Washington, DC

Diabetes, Lipid Metabolism, Thyroid

Professor of Medicine, Georgetown University

Dr. Burman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Burman's full profile

Already have an account?

  • Office

    110 Irving St NW
    # 2A38
    Washington, DC 20010
    Phone+1 202-877-2848
    Fax+1 202-877-2322

Education & Training

  • National Capital Consortium
    National Capital ConsortiumResidency, Internal Medicine, 1972 - 1974
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1970 - 1972
  • University of Missouri-Columbia School of Medicine
    University of Missouri-Columbia School of MedicineClass of 1970

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1994 - 2026
  • MO State Medical License
    MO State Medical License 1970 - 2025
  • DC State Medical License
    DC State Medical License 1973 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2011-2014
  • America's Top Doctors for Cancer Castle Connolly, 2011-2013
  • Top Doctors:Washington DC Area Castle Connolly, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Other

Press Mentions

  • Tackle the Triglycerides to Reduce ASCVD Risk, ACC Says
    Tackle the Triglycerides to Reduce ASCVD Risk, ACC SaysJuly 28th, 2021
  • First Thyroid Eye Disease Drug Wins over FDA Panel
    First Thyroid Eye Disease Drug Wins over FDA PanelDecember 13th, 2019
  • FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl
    FDA Advisors Recommend CVD Event Reduction Claim for Icosapent EthylNovember 14th, 2019
  • Join now to see all

Professional Memberships